•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Wall Street Analysts Believe Precision Drilling (PDS) Could Rally 26.28%: Here's is How to Trade
PDS Biotechnology Appoints Three Accomplished Pharma Industry Executives to Board of Directors
Should Value Investors Buy Precision Drilling (PDS) Stock?
PDS Biotechnology Targets Phase III Trial for PDS0301 in Metastatic Colorectal Cancer
Precision Drilling (TSE:PD) Shares Cross Above 50 Day Moving Average – What’s Next?
Comparing Precision Drilling (NYSE:PDS) and Solaris Energy Infrastructure (NYSE:SEI)
PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases
Precision Drilling Co. (TSE:PD) Stock Rated “Moderate Buy” by Wall Street Analysts
Are Investors Undervaluing Precision Drilling (PDS) Right Now?
Precision Drilling Corporation 2026 Third Quarter Results Conference Call and Webcast
PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology
Precision Drilling Corp (PDS) Stock Down 3.8% but Still Overvalued -- GF Score: 72/100
Precision Drilling Announces Renewal of Normal Course Issuer Bid
Trillium Acquisition Corp. Enters into Definitive Agreement to Complete Qualifying Transaction Involving SNFLWR Investment Corporation
Precision Drilling: U.S. Margin Recovery Could Drive A Rerating
PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks
Financial Survey: Precision Drilling (NYSE:PDS) and Technip Energies (OTCMKTS:THNPY)
Financial Contrast: STEP Energy Services (OTCMKTS:SNVVF) versus Precision Drilling (NYSE:PDS)
PDS Biotech Reports Second Quarter 2026 Financial Results
PDS Biotechnology Stock Crashes, Strategic Refocus Pivots to Metastatic Colorectal Cancer Program
Already premium?